Agile Therapeutics, Inc. (AGRX)

NASDAQ: AGRX · Delayed Price · USD
0.00 (0.00%)
At close: May 26, 2022 4:00 PM
-0.01 (-0.74%)
After-hours:May 26, 2022 4:18 PM EDT

Total Valuation

AGRX has a market cap or net worth of $6.13 million. The enterprise value is $15.35 million.

Market Cap6.13M
Enterprise Value15.35M

Important Dates

The latest earnings date was Thursday, May 12, 2022, after market close.

Last Earnings DateMay 12, 2022
Ex-Dividend Daten/a

Share Statistics

AGRX has 4.54 million shares outstanding. The number of shares has increased by 42.20% in one year.

Shares Outstanding4.54M
Shares Change (YoY)+42.20%
Shares Change (QoQ)+28.37%
Owned by Insiders (%)0.26%
Owned by Institutions (%)24.89%

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio1.07
PB Ratio2.24
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Sales2.67
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 0.56, with a Debt / Equity ratio of 4.72.

Current Ratio0.56
Quick Ratio0.21
Debt / Equity4.72
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -588.00%, which is considered low. The company has a ROIC of -349.20%.

Return on Equity (ROE)-588.00%
Return on Assets (ROA)-176.50%
Return on Capital (ROIC)-349.20%
Revenue Per Employee$191,567
Profits Per Employee-$2.32M
Employee Count30
Asset Turnover0.15
Inventory Turnover5.18


Income Tax-4.68M
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -97.91% in the last 52 weeks. The beta is 1.57, so AGRX's price volatility has been higher than the market average.

Beta (1Y)1.57
52-Week Price Change-97.91%
50-Day Moving Average3.64
200-Day Moving Average13.69
Average Volume (30 Days)389,733

Short Selling Information

The latest short interest is 221,714, so 4.88% of the outstanding shares have been sold short.

Short Interest221,714
Short % of Shares Out4.88%
Short % of Float5.57%
Short Ratio (days to cover)0.41

Income Statement

In the last 12 months, AGRX had revenue of $5.75 million and -69.54 million in losses. Earnings per share was -$26.16.

Gross Profit-5.34M
Operating Income-70.36M
Pretax Income-74.21M
Net Income-69.54M
Earnings Per Share (EPS)-$26.16
Full Income Statement

Balance Sheet

The company has $3.74 million in cash and $12.96 million in debt, giving a net cash position of -$9.22 million or -$2.03 per share.

Cash & Cash Equivalents3.74M
Total Debt12.96M
Net Cash-9.22M
Net Cash Per Share-$2.03
Book Value2.74M
Book Value Per Share0.60
Working Capital-11.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$65.29 million and capital expenditures -$324,000, giving a free cash flow of -$65.61 million.

Operating Cash Flow-65.29M
Capital Expenditures-324,000
Free Cash Flow-65.61M
FCF Per Sharen/a
Full Cash Flow Statement


Gross margin is -92.87%, with operating and profit margins of -1,224.22% and -1,209.94%.

Gross Margin-92.87%
Operating Margin-1,224.22%
Pretax Margin-1,291.28%
Profit Margin-1,209.94%
EBITDA Margin-1,184.64%
EBIT Margin-1,224.05%
FCF Margin-1,141.62%

Dividends & Yields

AGRX does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-1,134.00%
FCF Yield-1,069.97%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yield-42.20%
Shareholder Yield-42.20%
Dividend Details

Analyst Forecast

The average price target for AGRX is $102.00, which is 7,455.56% higher than the current price. The consensus rating is "Buy".

Price Target$102.00
Price Target Difference7,455.56%
Analyst ConsensusBuy
Analyst Count9
Stock Forecasts

Stock Splits

The last stock split was on April 27, 2022. It was a reverse split with a ratio of 1:40.

Last Split DateApr 27, 2022
Split TypeReverse
Split Ratio1:40